These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 9135409)

  • 1. Atropine penalisation versus occlusion as the primary treatment for amblyopia.
    Foley-Nolan A; McCann A; O'Keefe M
    Br J Ophthalmol; 1997 Jan; 81(1):54-7. PubMed ID: 9135409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atropine vs patching for treatment of moderate amblyopia: follow-up at 15 years of age of a randomized clinical trial.
    Repka MX; Kraker RT; Holmes JM; Summers AI; Glaser SR; Barnhardt CN; Tien DR;
    JAMA Ophthalmol; 2014 Jul; 132(7):799-805. PubMed ID: 24789375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Combined Occlusion and Atropine Therapy" Versus "Augmented Part-Time Patching" in Children with Refractory/Residual Amblyopia: A Pilot Study.
    Sachdeva V; Mittal V; Gupta V; Gunturu R; Kekunnaya R; Chandrasekharan A; Chabblani PP; Rao HL
    Middle East Afr J Ophthalmol; 2016; 23(2):201-7. PubMed ID: 27162453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined optical and atropine penalization for the treatment of strabismic and anisometropic amblyopia.
    Kaye SB; Chen SI; Price G; Kaye LC; Noonan C; Tripathi A; Ashwin P; Cota N; Clark D; Butcher J
    J AAPOS; 2002 Oct; 6(5):289-93. PubMed ID: 12381987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The course of moderate amblyopia treated with atropine in children: experience of the amblyopia treatment study.
    Pediatric Eye Disease Investigator Group
    Am J Ophthalmol; 2003 Oct; 136(4):630-9. PubMed ID: 14516802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance and patching and atropine amblyopia treatments.
    Wang J
    Vision Res; 2015 Sep; 114():31-40. PubMed ID: 25743080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amblyopia can be treated without occlusion or atropine.
    Isenberg SJ
    Ophthalmology; 2006 Jun; 113(6):893. PubMed ID: 16751031
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of atropine and patching treatments for moderate amblyopia by patient age, cause of amblyopia, depth of amblyopia, and other factors.
    Pediatric Eye Disease Investigator Group
    Ophthalmology; 2003 Aug; 110(8):1632-7; discussion 1637-8. PubMed ID: 12917184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of atropine vs patching for treatment of moderate amblyopia: follow-up at age 10 years.
    ; Repka MX; Kraker RT; Beck RW; Holmes JM; Cotter SA; Birch EE; Astle WF; Chandler DL; Felius J; Arnold RW; Tien DR; Glaser SR
    Arch Ophthalmol; 2008 Aug; 126(8):1039-44. PubMed ID: 18695096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children.
    Pediatric Eye Disease Investigator Group.
    Arch Ophthalmol; 2002 Mar; 120(3):268-78. PubMed ID: 11879129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial.
    Scheiman MM; Hertle RW; Kraker RT; Beck RW; Birch EE; Felius J; Holmes JM; Kundart J; Morrison DG; Repka MX; Tamkins SM;
    Arch Ophthalmol; 2008 Dec; 126(12):1634-42. PubMed ID: 19064841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children.
    Repka MX; Wallace DK; Beck RW; Kraker RT; Birch EE; Cotter SA; Donahue S; Everett DF; Hertle RW; Holmes JM; Quinn GE; Scheiman MM; Weakley DR;
    Arch Ophthalmol; 2005 Feb; 123(2):149-57. PubMed ID: 15710809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amblyopia treatment and quality of life: the child's perspective on atropine versus patching.
    Steel DA; Codina CJ; Arblaster GE
    Strabismus; 2019 Sep; 27(3):156-164. PubMed ID: 31329017
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical trial of patching versus atropine penalization for the treatment of anisometropic amblyopia in older children.
    Menon V; Shailesh G; Sharma P; Saxena R
    J AAPOS; 2008 Oct; 12(5):493-7. PubMed ID: 18534880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEDIG study on amblyopia; vision therapy by atropine penalization versus occlusion.
    Kowal L
    Binocul Vis Strabismus Q; 2002; 17(4):275. PubMed ID: 12470288
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized trial of treatment of amblyopia in children aged 7 to 17 years.
    Scheiman MM; Hertle RW; Beck RW; Edwards AR; Birch E; Cotter SA; Crouch ER; Cruz OA; Davitt BV; Donahue S; Holmes JM; Lyon DW; Repka MX; Sala NA; Silbert DI; Suh DW; Tamkins SM;
    Arch Ophthalmol; 2005 Apr; 123(4):437-47. PubMed ID: 15824215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conventional occlusion versus pharmacologic penalization for amblyopia.
    Li T; Shotton K
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006460. PubMed ID: 19821369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy of penalization methods in moderate to mild amblyopia.
    Tejedor J; Ogallar C
    Am J Ophthalmol; 2008 Mar; 145(3):562-9. PubMed ID: 18207121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the treatment of amblyopia.
    Quinn GE; Beck RW; Holmes JM; Repka MX;
    Pediatrics; 2004 Jun; 113(6):1800-2. PubMed ID: 15173508
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk factors for treatment failure of anisometropic amblyopia.
    Hussein MA; Coats DK; Muthialu A; Cohen E; Paysse EA
    J AAPOS; 2004 Oct; 8(5):429-34. PubMed ID: 15492734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.